Fortis Malar Hospitals Ltd: Fundamental Analysis, Share Price Insights & Intrinsic Value (2024)

Share Price and Basic Stock Data

Last Updated: December 21, 2024, 12:58 am

Market Cap	111 Cr.
Current Price	59.1
High / Low	108/44.0
Stock P/E
Book Value	15.9
Dividend Yield	71.9 %
ROCE	3.29 %
ROE	9.12 %
Face Value	10.0
PEG Ratio	0.00

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for

Competitors of

Stock Name	Market Cap	Current Price	High / Low	Stock P/E	Book Value	Dividend Yield	ROCE	ROE	Face Value
NG Industries Ltd	61.0 Cr.	182	230/136	10.4	124	1.92 %	6.50 %	5.63 %	10.0
Global Longlife Hospital and Research Ltd	32.0 Cr.	30.5	61.7/27.0		25.9	0.00 %	2.51 %	4.72 %	10.0
Gian Lifecare Ltd	19.6 Cr.	19.0	29.0/17.0	4.82	19.2	0.00 %	29.2 %	24.6 %	10.0
Fortis Malar Hospitals Ltd	111 Cr.	59.1	108/44.0		15.9	71.9 %	3.29 %	9.12 %	10.0
Family Care Hospitals Ltd	36.7 Cr.	6.79	10.3/6.23	0.89	2.67	0.00 %	15.4 %	24.1 %	10.0
Industry Average	25,292.00 Cr	771.73		53.92	89.62	3.18%	12.34%	12.42%	9.12

All Competitor Stocks of

Quarterly Result

Month	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Sales	19.93	20.45	22.62	20.10	23.29	21.90	20.66	17.76	18.15	17.58	5.52	0.00	0.00
Expenses	20.93	20.19	19.35	20.13	21.01	20.30	19.93	18.27	18.23	18.67	5.04	0.88	0.47
Operating Profit	-1.00	0.26	3.27	-0.03	2.28	1.60	0.73	-0.51	-0.08	-1.09	0.48	-0.88	-0.47
OPM %	-5.02%	1.27%	14.46%	-0.15%	9.79%	7.31%	3.53%	-2.87%	-0.44%	-6.20%	8.70%
Other Income	1.99	1.77	1.58	1.64	1.50	1.52	1.97	1.61	2.31	1.26	59.69	0.83	0.56
Interest	1.67	1.61	1.55	1.55	1.61	1.49	1.42	1.35	1.30	1.26	0.39	0.01	0.00
Depreciation	3.09	3.12	3.24	3.02	2.91	2.78	3.44	2.67	2.72	2.91	1.06	0.00	0.00
Profit before tax	-3.77	-2.70	0.06	-2.96	-0.74	-1.15	-2.16	-2.92	-1.79	-4.00	58.72	-0.06	0.09
Tax %	0.00%	0.00%	850.00%	0.00%	491.89%	0.00%	223.15%	0.00%	0.00%	0.25%	7.95%	0.00%	0.00%
Net Profit	-3.78	-2.70	-0.45	-2.96	-4.38	-1.15	-6.99	-2.93	-1.79	-4.00	54.05	-0.06	0.09
EPS in Rs	-2.02	-1.44	-0.24	-1.58	-2.34	-0.61	-3.73	-1.56	-0.96	-2.13	28.84	-0.03	0.05

Last Updated: November 6, 2024, 6:44 pm

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: Unknown

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	98	108	118	130	141	149	145	112	69	86	86	59	41
Expenses	86	99	110	123	140	147	147	115	76	83	81	60	43
Operating Profit	11	9	8	6	1	2	-2	-3	-6	3	5	-1	-2
OPM %	12%	8%	6%	5%	1%	1%	-2%	-2%	-9%	4%	5%	-2%	-4%
Other Income	49	7	8	7	8	8	10	11	15	7	7	65	64
Interest	1	0	1	0	0	0	1	8	7	7	6	4	3
Depreciation	2	2	3	3	4	4	4	13	13	13	12	9	7
Profit before tax	57	13	12	10	4	6	3	-12	-11	-8	-7	50	53
Tax %	24%	34%	34%	36%	30%	41%	26%	-25%	-30%	0%	121%	9%
Net Profit	43	9	8	6	3	3	2	-9	-8	-8	-15	45	48
EPS in Rs	23.38	4.72	4.23	3.45	1.67	1.78	1.10	-4.74	-4.20	-4.41	-8.26	24.18	25.72
Dividend Payout %	0%	11%	12%	14%	0%	0%	0%	0%	0%	0%	0%	176%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2013-2014	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	-79.07%	-11.11%	-25.00%	-50.00%	0.00%	-33.33%	-550.00%	11.11%	0.00%	-87.50%	400.00%
Change in YoY Net Profit Growth (%)	0.00%	67.96%	-13.89%	-25.00%	50.00%	-33.33%	-516.67%	561.11%	-11.11%	-87.50%	487.50%

has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	-6%
5 Years:	-16%
3 Years:	-5%
TTM:	-71%

Compounded Profit Growth
10 Years:	%
5 Years:	%
3 Years:	14%
TTM:	75%

Stock Price CAGR
10 Years:	6%
5 Years:	4%
3 Years:	-2%
1 Year:	-3%

Return on Equity
10 Years:	-3%
5 Years:	-13%
3 Years:	-13%
Last Year:	-9%

Last Updated: Unknown

Balance Sheet

Last Updated: November 14, 2024, 3:35 pm

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	19	19	19	19	19	19	19	19	19	19	19	19	19
Reserves	59	66	73	79	81	84	87	78	70	61	45	91	11
Borrowings	0	0	0	0	0	0	0	64	57	53	46	0	0
Other Liabilities	14	17	20	33	31	46	45	33	23	27	27	6	7
Total Liabilities	91	101	111	130	131	149	151	194	169	161	138	116	37
Fixed Assets	17	18	18	24	25	24	22	81	69	58	47	0	0
CWIP	0	1	1	0	1	1	1	0	0	0	0	0	0
Investments	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets	73	83	93	105	105	125	128	112	100	103	91	116	37
Total Assets	91	101	111	130	131	149	151	194	169	161	138	116	37

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	-64	5	4	10	-9	9	-16	-0	-1	7	6	-7
Cash from Investing Activity +	73	-1	5	-22	13	-2	6	50	-28	8	0	120
Cash from Financing Activity +	-7	-1	0	-1	-1	0	0	-12	-7	-10	-13	-11
Net Cash Flow	2	3	10	-13	4	7	-9	38	-36	5	-7	102

Free Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	11.00	9.00	8.00	6.00	1.00	2.00	-2.00	-67.00	-63.00	-50.00	-41.00	-1.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	12	13	13	17	14	15	24	12	11	9	14	-0
Inventory Days	7	4	13	35	28	22	18	22	42	40	32	-0
Days Payable	160	153	169	286	174	277	257	324	373	429	585
Cash Conversion Cycle	-141	-136	-143	-234	-131	-240	-215	-289	-320	-380	-539	-0
Working Capital Days	212	187	164	126	153	132	156	-55	134	51	219	-8
ROCE %	23%	17%	14%	12%	5%	6%	3%	-3%	-7%	-1%	-1%	-3%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Promoters	62.71%	62.71%	62.71%	62.71%	62.71%	62.71%	62.71%	62.71%	62.71%	62.71%	14.40%	62.71%
DIIs	0.07%	0.07%	0.07%	0.07%	0.07%	0.07%	0.07%	0.07%	0.07%	0.07%	0.17%	0.07%
Public	37.22%	37.22%	37.22%	37.23%	37.23%	37.23%	37.23%	37.23%	37.23%	37.23%	85.43%	37.22%
No. of Shareholders	9,365	9,688	9,578	9,520	8,772	8,731	8,651	8,630	9,790	10,213	16,452	18,860

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	24.18	-8.26	-4.41	-4.20	-4.75
Diluted EPS (Rs.)	24.18	-8.26	-4.41	-4.20	-4.75
Cash EPS (Rs.)	29.15	-1.78	2.27	2.67	1.94
Book Value[Excl.RevalReserv]/Share (Rs.)	58.36	34.21	42.72	47.31	51.40
Book Value[Incl.RevalReserv]/Share (Rs.)	58.36	34.21	42.72	47.31	51.40
Revenue From Operations / Share (Rs.)	31.46	45.82	45.94	36.92	59.64
PBDIT / Share (Rs.)	3.06	5.98	5.77	1.02	4.48
PBIT / Share (Rs.)	-1.93	-0.49	-0.90	-5.84	-2.20
PBT / Share (Rs.)	26.66	-3.74	-4.40	-6.03	-6.36
Net Profit / Share (Rs.)	24.16	-8.25	-4.41	-4.20	-4.74
NP After MI And SOA / Share (Rs.)	24.16	-8.25	-4.41	-4.20	-4.74
PBDIT Margin (%)	9.74	13.04	12.56	2.76	7.51
PBIT Margin (%)	-6.12	-1.09	-1.97	-15.82	-3.68
PBT Margin (%)	84.74	-8.15	-9.58	-16.33	-10.66
Net Profit Margin (%)	76.81	-18.01	-9.60	-11.36	-7.94
NP After MI And SOA Margin (%)	76.81	-18.01	-9.60	-11.36	-7.94
Return on Networth / Equity (%)	41.40	-24.12	-10.32	-8.86	-9.22
Return on Capital Employeed (%)	-3.29	-0.88	-1.31	-7.59	-2.61
Return On Assets (%)	39.11	-11.21	-5.14	-4.65	-4.59
Asset Turnover Ratio (%)	0.46	0.57	0.52	0.38	0.65
Current Ratio (X)	17.68	2.66	1.56	2.43	1.74
Quick Ratio (X)	17.68	2.63	1.50	2.36	1.70
Interest Coverage Ratio (X)	1.34	1.85	1.65	0.26	1.08
Interest Coverage Ratio (Post Tax) (X)	-1.93	-1.55	-0.26	-1.04	-0.13
Enterprise Value (Cr.)	-20.82	80.00	95.58	90.44	37.40
EV / Net Operating Revenue (X)	-0.35	0.93	1.11	1.31	0.33
EV / EBITDA (X)	-3.62	7.14	8.83	47.25	4.45
MarketCap / Net Operating Revenue (X)	1.48	1.04	1.25	1.50	0.72
Price / BV (X)	0.79	1.39	1.35	1.17	0.83
Price / Net Operating Revenue (X)	1.48	1.04	1.25	1.50	0.72
EarningsYield	0.51	-0.17	-0.07	-0.07	-0.11

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of as of December 22, 2024 is: 37.39

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of December 22, 2024, is Overvalued by 36.73% compared to the current share price 59.10

Default values used*: Default value of 15 for Stock P/E is used

Intrinsic Value of as of December 22, 2024 is: 74.27

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of December 22, 2024, is Undervalued by 25.67% compared to the current share price 59.10

Default values used*: Default value of 15 for Stock P/E is used

Last 5 Year EPS CAGR: 98.63%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a low average Cash Conversion Cycle of -230.67, which is a positive sign. The company has higher reserves (68.08 cr) compared to borrowings (16.92 cr), indicating strong financial stability. The company has shown consistent growth in sales (103.23 cr) and profit (13.08 cr) over the years.	The stock has a low average ROCE of 5.42%, which may not be favorable. The stock has a high average Working Capital Days of 122.58, which may not be favorable.

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in :
1. Net Profit Margin: 76.81%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: -3.29% (Industry Average ROCE: 12.34%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 41.4% (Industry Average ROE: 11.92%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): -1.93
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 17.68
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 0 (Industry average Stock P/E: 43.14)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Fortis Malar Hospitals Ltd. is a Public Limited Listed company incorporated on 13/04/1989 and has its registered office in the State of Tamil Nadu, India. Company’s Corporate Identification Number(CIN) is L85110PB1989PLC045948 and registration number is 045948. Currently Company is involved in the business activities of Hospital activities. Company’s Total Operating Revenue is Rs. 86.18 Cr. and Equity Capital is Rs. 18.76 Cr. for the Year ended 31/03/2022.

INDUSTRY	ADDRESS	CONTACT
Hospitals & Medical Services	Fortis Hospital, Mohali Punjab 160062	secretarial.malar@malarhospitals.in http://www.fortismalarhospital.com

Management
Name	Position Held
Mr. Daljit Singh	Chairman, Non Ind & Non Exe Director
Mr. Chandrasekar Ramasamy	Whole Time Director
Ms. Richa Singh Debgupta	Non Exe.Non Ind.Director
Mr. Ramesh L Adige	Ind. Non-Executive Director
Ms. Shailaja Chandra	Ind. Non-Executive Director
Mr. Ravi Rajagopal	Ind. Non-Executive Director

FAQ

What is the latest intrinsic value of ?

The latest intrinsic value of as on 22 December 2024 is ₹37.39, which is 36.73% lower than the current market price of ₹59.10. The stock has a market capitalization of 111 Cr. and recorded a high/low of 108/44.0 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹11 Cr and total liabilities of ₹37 Cr.

What is the Market Cap of ?

The Market Cap of is 111 Cr..

What is the current Stock Price of as on 22 December 2024?

The current stock price of as on 22 December 2024 is 59.1.

What is the High / Low of stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of stocks is 108/44.0.

What is the Stock P/E of ?

The Stock P/E of is .

What is the Book Value of ?

The Book Value of is 15.9.

What is the Dividend Yield of ?

The Dividend Yield of is 71.9 %.

What is the ROCE of ?

The ROCE of is 3.29 %.

What is the ROE of ?

The ROE of is 9.12 %.

What is the Face Value of ?

The Face Value of is 10.0.